4//SEC Filing
BRYCE RICHARD PAUL 4
Accession 0001209191-20-061811
CIK 0001401667other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:34 PM ET
Size
4.9 KB
Accession
0001209191-20-061811
Insider Transaction Report
Form 4
BRYCE RICHARD PAUL
SR VP, CLINICAL RESEARCH & DEV
Transactions
- Sale
COMMON STOCK
2020-12-02$11.65/sh−92$1,072→ 76,627 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001553037
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:34 PM ET
- Size
- 4.9 KB